AR and polycystic ovary syndrome: A potentially effective strategy is to target AR-signalling in neuroendocrine pathways, as specific loss of AR actions in the brain prevented hyperandrogenized mice from developing PCOS traits, identifying the brain as a main site involved in experimental PCOS [45].